2026 · Wikipedia
Neuralink
Neuralink, co-founded by Musk in 2016 with a $100 million investment, pursues the integration of the human brain with artificial intelligence through implanted devices intended to enhance memory or communicate directly with software, and to treat neurological conditions such as spinal-cord injuries. The development path has been as controversial as the ambition is grand. The company's animal trials on macaques at the University of California, Davis, including a 2021 video of a monkey playing Pong through a Neuralink implant, produced cruelty allegations from the Physicians Committee for Responsible Medicine, employee complaints that Musk's pressure to accelerate development produced botched experiments and unnecessary animal deaths, and a 2022 federal probe into possible welfare violations. Clinical trials were promised for late 2022, and in September 2023 the Food and Drug Administration approved the initiation of six-year human trials, opening the regulatory gate the company had missed on its original schedule.